VA

VR Adviser Portfolio holdings

AUM $1.33B
1-Year Est. Return 6.92%
This Quarter Est. Return
1 Year Est. Return
+6.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.33B
AUM Growth
+$159M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
40
New
Increased
Reduced
Closed

Top Buys

1
+$34.7M
2
+$32.2M
3
+$31.7M
4
CBIO
Crescent Biopharma
CBIO
+$21.9M
5
SVRA icon
Savara
SVRA
+$12.8M

Top Sells

1
+$37.5M
2
+$20.1M
3
+$18.7M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$13.9M
5
SLDB icon
Solid Biosciences
SLDB
+$9.18M

Sector Composition

1 Healthcare 99.4%
2 Financials 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEPN
26
Septerna Inc
SEPN
$975M
$5.71M 0.43%
+540,453
SRZN icon
27
Surrozen
SRZN
$118M
$5.66M 0.42%
632,931
ZURA icon
28
Zura Bio
ZURA
$231M
$4.86M 0.36%
4,631,216
-391,950
ARTV
29
Artiva Biotherapeutics
ARTV
$128M
$2.43M 0.18%
1,609,569
CASI icon
30
CASI Pharmaceuticals
CASI
$25.6M
$1.16M 0.09%
987,259
TENX icon
31
Tenax Therapeutics
TENX
$33.6M
$568K 0.04%
98,564
-109,769
APLT icon
32
Applied Therapeutics
APLT
$193M
– –
-5,567,709
FDMT icon
33
4D Molecular Therapeutics
FDMT
$511M
– –
-677,600
IPSC icon
34
Century Therapeutics
IPSC
$51.4M
– –
-2,498,069
MRSN icon
35
Mersana Therapeutics
MRSN
$47.7M
– –
-142,973
PRAX icon
36
Praxis Precision Medicines
PRAX
$3.75B
– –
-989,985
SLDB icon
37
Solid Biosciences
SLDB
$436M
– –
-2,481,400
TIL icon
38
Instil Bio
TIL
$132M
– –
-33,177
TNYA icon
39
Tenaya Therapeutics
TNYA
$277M
– –
-1,555,556
TRVI icon
40
Trevi Therapeutics
TRVI
$1.32B
– –
-615,506
1
2